Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05910502 · ClinicalTrials.gov registry record · NA

Project AFECT (Autism Family Empowerment Coaching and Training Program)

A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

Active
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT05910502: Active NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

NCT05910502 is a NA study of Autism Spectrum Disorder and Autism that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 200 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (49% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05910502, a NA study of Autism Spectrum Disorder and Autism, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical trial is to learn about the journey of families after their child's diagnosis of autism and to help parents understand autism and get the right treatments for their child. This study is for parents of children just diagnosed with autism who are: * Age greater than 1 and up to 5 years old; * Hispanic/Latino OR Black/African-American OR have Medi-Cal as primary health insurance; AND * Live in one of the following counties in California (Alameda, Contra Costa, Marin, Monterey, Napa, San Benito, San Francisco, San Mateo, Santa Clara, Santa Cruz, Solano, or Sonoma). The main questions it aims to answer are: * Whether parent coaching through Project AFECT leads to decreased parental stress and increased parental confidence; * Whether family navigation through Project AFECT leads to increased number of referrals to early intervention and educational services and reduced wait times to autism treatments; * Whether children whose parents receive Project AFECT intervention show increased language skills compared to children whose parents did not receive intervention. Participants will be asked to: * Complete surveys at enrollment and 3 and 6 months later. * Work with Project AFECT Coach. Researchers will compare control and intervention groups to see if Project AFECT leads to improved parent and child outcomes.

Primary Outcome

Mean change from baseline in parental self-efficacy measured using Autism-Specific Parenting Self-Efficacy Scale (PSEaS). Overall possible scores on the scale range from 17 - 85. The higher the score, the higher the measured level of parental self-efficacy (better outcome).

Interventions

  • BEHAVIORAL Autism Family Empowerment Coaching and Training Program

Study Locations (2)

California

  • Gardner Packard Children's Health Center - Atherton
  • Stanford Medicine Children's Health - Sunnyvale

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-09-19
Est. Completion 2026-12-31
Phase NA
Stanford University

1,744 total trials

What the registry record for NCT05910502 still lists

NCT05910502 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (49% higher).

The record links to 7 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Autism Family Empowerment Coaching and Training Program is the first listed.

NCT05910502 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05910502 about?

NCT05910502 is a clinical study titled "Project AFECT (Autism Family Empowerment Coaching and Training Program)". The goal of this clinical trial is to learn about the journey of families after their child's diagnosis of autism and to help parents understand autism and get the right treatments for their child. This study is for parents of children just diagnosed with autism who are: * Age greater than 1 and up...

What is the current status of trial NCT05910502?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-09-19. Estimated completion is 2026-12-31.

What conditions does trial NCT05910502 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism, Autistic Disorder, Autism Spectrum Disorders, Autistic Disorders Spectrum.

What interventions are being tested in trial NCT05910502?

The interventions under investigation include: Autism Family Empowerment Coaching and Training Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05910502?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05910502 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05910502's enrollment target sits among peer trials

200 39th of 224 higher than 184 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05910502, the US trial registry maintained by the National Library of Medicine. NCT05910502 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.